Loading provider…
Loading provider…
Urology Physician in Sudbury, MA
NPI: 1134184815Primary Practice Location
EMERSON HOSPITAL -
133 Old Rd To 9 Acre Cor, Concord, MA
Primary Employer
Emerson Practice Associates, Inc.
emersonhealth.org
HQ Phone
Get MD Jason's Phone Numberphone_androidMobile
Get MD Jason's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 282 | 383 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 161 | 223 |
| 3 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 88 | 106 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 31 | 31 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 30 | 30 |
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.
Authors: Howard Bailey, George Wilding, David Jarrard
Publication Date: 2012-08-17
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
Authors: Howard Bailey, Tracy Downs
Publication Date: 2016-06-22
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, PROCEDURE: Therapeutic Conventional Surgery, OTHER: Quality-of-Life Assessment, DRUG: Erlotinib Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Pomegranate-Extract Pill